This trial is unknown status.

Condition cocaine-related disorders
Treatment cocaine (iv)
Phase phase 1
Sponsor National Institute on Drug Abuse (NIDA)
Start date May 2002
End date August 2003
Trial size 32 participants
Trial identifier NCT00040066, NIDA-CTO-0013-1


The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model parallel assignment
Masking double-blind
Primary purpose treatment

Primary Outcomes

Cocaine craving
time frame:
Cocaine related high
time frame:

Eligibility Criteria

Male or female participants from 18 years up to 55 years old.

Inclusion Criteria: - Cocaine dependent, non treatment seeking individuals Exclusion Criteria: Please contact site directly for details.

Additional Information

Official title Development of Human Laboratory Study Model of Cocaine Relapse Prevention
Principal investigator John Roache, Ph.D.
Description The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA).